Idenix Pharmaceuticals

Idenix Pharmaceuticals

Verified
Discovery and development of drugs for the treatment of human viral diseases

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$3.9b (Public information from Jun 2014)
Cambridge Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
N/A$140mIPO
$20mLate VC
N/A$5mLate VC
$107mPost IPO Equity
$3.9b
Valuation: $3.9b
Acquisition
Total Funding$25m

Recent News about Idenix Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.